1. At a Glance – The Chemical Factory That Forgot to Print Profits
If Valiant Organics was a Bollywood character, it would be that comeback hero who gives a powerful interval performance… and then forgets the climax.
Here’s the masala:
- Revenue stable, margins improving
- PAT suddenly turns positive (after embarrassing losses)
- EBITDA margin jumps like it discovered protein powder
- But… ROE is still negative, debt exists, and stock has been falling like a crypto influencer’s credibility
This is a classic “numbers look better but soul still confused” story.
Let’s decode the contradictions:
- 9M FY26 PAT = ₹175 Cr vs loss last year
- EBITDA margin improved to ~11.82%
- But ROE = -0.51% and ROCE ~2.63%
So the question is:
If profits are back, why is capital still giving zero returns?
Either:
- profits are temporary
- or capital is bloated
- or business is still recovering from past damage
Or all three.
And that’s where things get interesting.
2. Introduction – From Superstar to Side Role, Now Trying Comeback
Valiant Organics was not always this confused.
Back in FY23:
- Revenue = ₹10,518 Mn
- PAT = ₹1,026 Mn
- EBITDA margin = 15.62%
Then suddenly:
- FY24: LOSS
- FY25: LOSS
- FY26: “Sir, we are back… maybe?”
This is not a slowdown. This is a financial whiplash.
Why did it happen?
The company itself admits:
- pricing pressure
- demand softness
- margin collapse
And CRISIL adds more spice:
- working capital heavy business
- margins volatile
- exposure to cyclical industries
Basically:
Valiant doesn’t control its destiny. The market does.
So the comeback story depends not just on management…
…but on chemicals cycle, demand cycle, and global pricing.
Tell me honestly:
Would you trust a business where your profit depends on China sneezing?
3. Business Model – WTF Do They Even Do?
Let’s simplify this chemical jungle.
Valiant Organics makes intermediate chemicals — not final products.
Meaning:
They sell ingredients, not finished goods.
Think:
- Pharma companies → need intermediates
- Dye manufacturers → need raw inputs
- Agrochemical companies → need compounds
Valiant supplies all of them.
Their main “chemistries”:
- Hydrogenation → 50% revenue
- Ammonolysis → 25%
- Chlorination → 20%
So essentially:
They convert basic chemicals into slightly more complex chemicals… and sell to bigger companies.
Not sexy. But critical.
The Real Business Truth
This is a B2B commodity-plus business.
Translation:
- Pricing power = limited
- Margins = cyclical
- Volume growth = dependent on industries
Even worse:
- 52% revenue comes from dyes & pigments
- 25% from agrochemicals
So if dyes industry slows down…
Valiant also goes on leave.
The Only Interesting Part
They are trying:
- backward integration (make own raw materials)
- forward integration
